| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.04e-04 | 5 | 65 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.74e-04 | 363 | 65 | 7 | GO:0106310 | |
| Domain | ARM-type_fold | TNPO1 DOCK2 DOCK3 JUP URB1 MTOR AP1G2 PSMD2 CUL7 MEI1 HEATR5B | 1.59e-08 | 339 | 63 | 11 | IPR016024 |
| Domain | ARM-like | 2.89e-07 | 270 | 63 | 9 | IPR011989 | |
| Domain | - | 9.59e-06 | 222 | 63 | 7 | 1.25.10.10 | |
| Domain | DOCK_N | 1.11e-04 | 5 | 63 | 2 | PF16172 | |
| Domain | DOCK_N | 1.11e-04 | 5 | 63 | 2 | IPR032376 | |
| Domain | AC_N | 3.09e-04 | 8 | 63 | 2 | IPR032628 | |
| Domain | Adcy | 3.09e-04 | 8 | 63 | 2 | IPR030672 | |
| Domain | AC_N | 3.09e-04 | 8 | 63 | 2 | PF16214 | |
| Domain | DOCK_C | 6.04e-04 | 11 | 63 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 6.04e-04 | 11 | 63 | 2 | IPR027007 | |
| Domain | DHR_2 | 6.04e-04 | 11 | 63 | 2 | PS51651 | |
| Domain | DHR_1 | 6.04e-04 | 11 | 63 | 2 | PS51650 | |
| Domain | DOCK-C2 | 6.04e-04 | 11 | 63 | 2 | PF14429 | |
| Domain | DHR-2 | 6.04e-04 | 11 | 63 | 2 | IPR027357 | |
| Domain | DHR-2 | 6.04e-04 | 11 | 63 | 2 | PF06920 | |
| Domain | DOCK | 6.04e-04 | 11 | 63 | 2 | IPR026791 | |
| Domain | HEAT | 9.89e-04 | 58 | 63 | 3 | IPR000357 | |
| Domain | Ser/Thr_kinase_AS | 1.27e-03 | 357 | 63 | 6 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 1.36e-03 | 362 | 63 | 6 | PS00108 | |
| Domain | A/G_cyclase_CS | 1.47e-03 | 17 | 63 | 2 | IPR018297 | |
| Domain | Nucleotide_cyclase | 1.65e-03 | 18 | 63 | 2 | IPR029787 | |
| Domain | - | 1.65e-03 | 18 | 63 | 2 | 3.30.70.1230 | |
| Domain | HEAT_REPEAT | 1.70e-03 | 70 | 63 | 3 | PS50077 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.85e-03 | 19 | 63 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 1.85e-03 | 19 | 63 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.85e-03 | 19 | 63 | 2 | PS50125 | |
| Domain | A/G_cyclase | 1.85e-03 | 19 | 63 | 2 | IPR001054 | |
| Domain | CYCc | 1.85e-03 | 19 | 63 | 2 | SM00044 | |
| Domain | Kinase-like_dom | 2.26e-03 | 542 | 63 | 7 | IPR011009 | |
| Domain | SH3_2 | 3.07e-03 | 86 | 63 | 3 | IPR011511 | |
| Domain | SH3_2 | 3.07e-03 | 86 | 63 | 3 | PF07653 | |
| Domain | PROTEIN_KINASE_ATP | 4.44e-03 | 459 | 63 | 6 | PS00107 | |
| Domain | Prot_kinase_dom | 6.02e-03 | 489 | 63 | 6 | IPR000719 | |
| Domain | SH3 | 6.08e-03 | 216 | 63 | 4 | SM00326 | |
| Domain | SH3 | 6.08e-03 | 216 | 63 | 4 | PS50002 | |
| Domain | PROTEIN_KINASE_DOM | 6.25e-03 | 493 | 63 | 6 | PS50011 | |
| Domain | SH3_domain | 6.49e-03 | 220 | 63 | 4 | IPR001452 | |
| Pubmed | Disruption of Epac1 protects the heart from adenylyl cyclase type 5-mediated cardiac dysfunction. | 3.55e-06 | 2 | 66 | 2 | 27117748 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 28316073 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22173835 | ||
| Pubmed | 3.92e-06 | 653 | 66 | 9 | 22586326 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29037982 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 19725049 | ||
| Pubmed | Chromosomal mapping of human adenylyl cyclase genes type III, type V and type VI. | 1.06e-05 | 3 | 66 | 2 | 8034296 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 14579029 | ||
| Pubmed | 3.42e-05 | 33 | 66 | 3 | 26296893 | ||
| Pubmed | mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. | 3.53e-05 | 5 | 66 | 2 | 20543138 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 17588951 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 21228155 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 21939655 | ||
| Pubmed | Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. | 3.53e-05 | 5 | 66 | 2 | 23363625 | |
| Pubmed | mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state. | 3.53e-05 | 5 | 66 | 2 | 23394946 | |
| Pubmed | Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts. | 3.53e-05 | 5 | 66 | 2 | 20232298 | |
| Pubmed | 3.71e-05 | 484 | 66 | 7 | 31995728 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.22e-05 | 1105 | 66 | 10 | 35748872 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 18339839 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 23540699 | ||
| Pubmed | Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. | 5.29e-05 | 6 | 66 | 2 | 17557924 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 5.29e-05 | 6 | 66 | 2 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 5.29e-05 | 6 | 66 | 2 | 11549699 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 6.32e-05 | 220 | 66 | 5 | 34091597 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 12613887 | ||
| Pubmed | The interaction of Epac1 and Ran promotes Rap1 activation at the nuclear envelope. | 7.40e-05 | 7 | 66 | 2 | 20547757 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 15004009 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.02e-04 | 989 | 66 | 9 | 36424410 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.18e-04 | 582 | 66 | 7 | 20467437 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 1.27e-04 | 9 | 66 | 2 | 17229090 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.32e-04 | 1024 | 66 | 9 | 24711643 | |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | 1.46e-04 | 419 | 66 | 6 | 33001583 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.46e-04 | 1284 | 66 | 10 | 17353931 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 1.52e-04 | 607 | 66 | 7 | 39147351 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.58e-04 | 10 | 66 | 2 | 8663304 | |
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 16615126 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 20301310 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.58e-04 | 10 | 66 | 2 | 11884542 | |
| Pubmed | Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. | 1.93e-04 | 11 | 66 | 2 | 29849151 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 10089566 | ||
| Pubmed | Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. | 1.93e-04 | 11 | 66 | 2 | 27766308 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 10808179 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.99e-04 | 1082 | 66 | 9 | 38697112 | |
| Pubmed | 2.07e-04 | 60 | 66 | 3 | 26472337 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 27782176 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 10807185 | ||
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 21930703 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 3.18e-04 | 14 | 66 | 2 | 14993377 | |
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 12432077 | ||
| Pubmed | 3.21e-04 | 312 | 66 | 5 | 37120454 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 3.37e-04 | 1425 | 66 | 10 | 30948266 | |
| Pubmed | 3.45e-04 | 1429 | 66 | 10 | 35140242 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 3.57e-04 | 925 | 66 | 8 | 28986522 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.64e-04 | 497 | 66 | 6 | 36774506 | |
| Pubmed | 3.66e-04 | 1440 | 66 | 10 | 30833792 | ||
| Pubmed | An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice. | 3.67e-04 | 15 | 66 | 2 | 28457749 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 4.03e-04 | 942 | 66 | 8 | 31073040 | |
| Pubmed | 4.09e-04 | 329 | 66 | 5 | 17474147 | ||
| Pubmed | 4.14e-04 | 183 | 66 | 4 | 23956138 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 17567809 | ||
| Pubmed | Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. | 4.74e-04 | 17 | 66 | 2 | 17322895 | |
| Pubmed | Association analysis of 3p21 with Crohn's disease in a New Zealand population. | 4.74e-04 | 17 | 66 | 2 | 20307617 | |
| Pubmed | 4.74e-04 | 17 | 66 | 2 | 10668806 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.76e-04 | 1489 | 66 | 10 | 28611215 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.87e-04 | 736 | 66 | 7 | 29676528 | |
| Pubmed | Integrin-linked kinase is an adaptor with essential functions during mouse development. | 5.32e-04 | 18 | 66 | 2 | 19829382 | |
| Pubmed | 5.32e-04 | 18 | 66 | 2 | 16484223 | ||
| Pubmed | 5.38e-04 | 83 | 66 | 3 | 9039502 | ||
| Pubmed | Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z-Line Proteins. | 5.94e-04 | 19 | 66 | 2 | 27171814 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.00e-04 | 358 | 66 | 5 | 32460013 | |
| Pubmed | 6.01e-04 | 202 | 66 | 4 | 24639526 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 6.17e-04 | 1005 | 66 | 8 | 19615732 | |
| Pubmed | Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. | 6.59e-04 | 20 | 66 | 2 | 19626040 | |
| Pubmed | 6.59e-04 | 20 | 66 | 2 | 32702291 | ||
| Pubmed | 7.45e-04 | 214 | 66 | 4 | 22199357 | ||
| Pubmed | 7.50e-04 | 93 | 66 | 3 | 27215380 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 7.98e-04 | 95 | 66 | 3 | 29643511 | |
| Pubmed | 7.99e-04 | 22 | 66 | 2 | 36877136 | ||
| Pubmed | 8.50e-04 | 809 | 66 | 7 | 32129710 | ||
| Pubmed | 8.99e-04 | 591 | 66 | 6 | 15231748 | ||
| Pubmed | 9.13e-04 | 226 | 66 | 4 | 31452512 | ||
| Pubmed | 9.43e-04 | 396 | 66 | 5 | 26687479 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.00e-03 | 1353 | 66 | 9 | 29467282 | |
| Pubmed | 1.01e-03 | 1084 | 66 | 8 | 11544199 | ||
| Pubmed | SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion. | 1.03e-03 | 25 | 66 | 2 | 27480238 | |
| Pubmed | 1.03e-03 | 25 | 66 | 2 | 38877142 | ||
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 1.03e-03 | 25 | 66 | 2 | 28154160 | |
| Pubmed | 1.04e-03 | 104 | 66 | 3 | 9205841 | ||
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 1.21e-03 | 27 | 66 | 2 | 23027611 | |
| Pubmed | 1.21e-03 | 27 | 66 | 2 | 12836198 | ||
| Pubmed | 1.29e-03 | 634 | 66 | 6 | 34591612 | ||
| Pubmed | 1.36e-03 | 641 | 66 | 6 | 36057605 | ||
| Pubmed | Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. | 1.45e-03 | 117 | 66 | 3 | 34662580 | |
| Pubmed | 1.50e-03 | 653 | 66 | 6 | 33742100 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.51e-03 | 1155 | 66 | 8 | 20360068 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.57e-03 | 262 | 66 | 4 | 36880596 | |
| Pubmed | 1.70e-03 | 32 | 66 | 2 | 19815544 | ||
| Pubmed | 1.80e-03 | 33 | 66 | 2 | 23118208 | ||
| Pubmed | 1.80e-03 | 33 | 66 | 2 | 25582440 | ||
| Interaction | FEZ2 interactions | 1.03e-05 | 45 | 61 | 4 | int:FEZ2 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.57e-04 | 10 | 44 | 2 | 53 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-06 | 158 | 65 | 5 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.99e-06 | 170 | 65 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 5.59e-06 | 174 | 65 | 5 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 175 | 65 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 175 | 65 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.91e-06 | 176 | 65 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.96e-06 | 182 | 65 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-06 | 185 | 65 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 7.60e-05 | 154 | 65 | 4 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 9.02e-05 | 161 | 65 | 4 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-04 | 170 | 65 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 172 | 65 | 4 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 1.19e-04 | 173 | 65 | 4 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 173 | 65 | 4 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.19e-04 | 173 | 65 | 4 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 65 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.27e-04 | 176 | 65 | 4 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 178 | 65 | 4 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.36e-04 | 179 | 65 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 181 | 65 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.48e-04 | 183 | 65 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-04 | 184 | 65 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-04 | 187 | 65 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.60e-04 | 187 | 65 | 4 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 188 | 65 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 188 | 65 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-04 | 188 | 65 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.67e-04 | 189 | 65 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.67e-04 | 189 | 65 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 190 | 65 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-04 | 190 | 65 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-04 | 190 | 65 | 4 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-04 | 190 | 65 | 4 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 1.78e-04 | 192 | 65 | 4 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 192 | 65 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 192 | 65 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.78e-04 | 192 | 65 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 193 | 65 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 194 | 65 | 4 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 195 | 65 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 195 | 65 | 4 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 195 | 65 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-04 | 197 | 65 | 4 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-04 | 197 | 65 | 4 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 2.08e-04 | 200 | 65 | 4 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | AC1Q3G0K | 7.26e-07 | 60 | 64 | 5 | CID000002087 | |
| Drug | Gvapspat amide | 9.41e-06 | 15 | 64 | 3 | CID000125015 | |
| Drug | racemic timolol | 1.28e-05 | 51 | 64 | 4 | CID000005478 | |
| Drug | SK&F 82958 | 1.99e-05 | 19 | 64 | 3 | ctd:C071262 | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 7343_DN | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 2.85e-05 | 568 | 64 | 9 | CID000000806 | |
| Drug | alprenolol | 3.18e-05 | 64 | 64 | 4 | CID000002119 | |
| Disease | Malformations of Cortical Development | 4.14e-04 | 14 | 64 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 4.14e-04 | 14 | 64 | 2 | C0431380 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 5.45e-04 | 16 | 64 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | body mass index, type 2 diabetes mellitus | 5.45e-04 | 16 | 64 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.17e-04 | 17 | 64 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | body fat percentage | 6.61e-04 | 488 | 64 | 6 | EFO_0007800 | |
| Disease | Neurodevelopmental Disorders | 1.10e-03 | 93 | 64 | 3 | C1535926 | |
| Disease | eosinophil percentage of leukocytes | 1.14e-03 | 746 | 64 | 7 | EFO_0007991 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.17e-03 | 364 | 64 | 5 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | creatinine measurement | 1.35e-03 | 995 | 64 | 8 | EFO_0004518 | |
| Disease | eosinophil percentage of granulocytes | 1.69e-03 | 234 | 64 | 4 | EFO_0007996 | |
| Disease | Epileptic encephalopathy | 1.94e-03 | 30 | 64 | 2 | C0543888 | |
| Disease | Severe Congenital Microcephaly | 2.07e-03 | 31 | 64 | 2 | C3853041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLELMAEFLRAEMAR | 66 | A1L162 | |
| LRPHKLMIMLRSIRE | 331 | Q8NHY0 | |
| NREHLAMMERILGPI | 386 | P49760 | |
| HMRAAILEKMPLVER | 576 | O75843 | |
| MRPEDRMFHIRAVIL | 1 | P20036 | |
| LLLSVLPRHVAMEMK | 431 | O95622 | |
| RVHNLITDFLALMPM | 391 | Q92621 | |
| LIFLIMTERSLHEPM | 31 | P0C646 | |
| LFHMPRKRMISLRFL | 1106 | Q504Q3 | |
| DLVRRMLMLDPAERI | 251 | O14936 | |
| HTFRSDLREEILMLM | 521 | Q96EY7 | |
| MVDELVLLLHALLMR | 1 | O95751 | |
| LLIRMEVFPEHLARF | 756 | Q9NRM7 | |
| TMLLPPLRERMELLH | 851 | Q15751 | |
| MMKRIHSLLERYPEI | 656 | Q5H9U9 | |
| EQDPRALHMERLMRL | 731 | O14782 | |
| ALHMERLMRLDSFLE | 736 | O14782 | |
| ILLLVMDVRLHTPMY | 46 | A6NFC9 | |
| VFKDPRVLDLLMHML | 156 | Q14999 | |
| MALFRLVEPMAGRIL | 1186 | Q96J66 | |
| IDRLRVLLMLFHTMA | 11 | Q9UJQ1 | |
| TSLELPMAMRFRHLK | 2556 | Q9UMN6 | |
| ALHILARDPMNRMEI | 566 | P14923 | |
| SFLRPEILRLMTLFM | 1166 | Q5TIA1 | |
| QMAELRILRLMPADA | 2521 | Q5VST9 | |
| MARHLLLPLVMLVIS | 1 | Q5K4E3 | |
| RLAAMLTLPEDLARM | 491 | Q9P2J9 | |
| MELLMFILVRHMPHL | 1716 | Q9P2D3 | |
| LMSMEPRRLEPAHLA | 921 | A4D2P6 | |
| AVPIEDMQRIHLRFM | 496 | Q92608 | |
| DKYRHAREMMLLLPT | 1771 | Q8IZD9 | |
| MARGMAFLHTLEPLI | 301 | Q13418 | |
| RFREHDLPMVALEQM | 806 | O60266 | |
| MHRSEPFLKMSLLIL | 1 | A0A1B0GTR0 | |
| MRLKHLDMVLPEVAS | 356 | Q92551 | |
| LMALRLLSRLLAHMP | 2061 | Q5TBA9 | |
| FLLPMFRHIMDQRSL | 426 | Q7L014 | |
| HKIEMLDRLLRAIYM | 131 | Q02742 | |
| DLFRIPMLRRMTFCL | 316 | Q8TCC7 | |
| RPSMMQHLLRRLVFD | 2581 | Q92736 | |
| MHKRRIAMLEPLTVD | 446 | Q96EK5 | |
| PRRIHMMSLGVLNLA | 261 | Q8N9I5 | |
| RIMLRMAPDYDHLTL | 2266 | P42345 | |
| MVHPVAERLDILMSL | 306 | Q9NYV6 | |
| LLRLRMREELSAAPM | 276 | Q7L2K0 | |
| RFPEALRLALMLNDM | 261 | Q13200 | |
| RMAFPLLDMVDLERR | 161 | Q9BXW7 | |
| MERIMDLPTLLRHAF | 171 | Q96K19 | |
| DLLPVGMHRILMLVR | 986 | P08F94 | |
| LLDRDRMMQTILHFP | 1596 | O60287 | |
| MMEELHSLDPRRQEL | 1 | Q86UE8 | |
| MMLAQGLLLHFLPRD | 151 | Q86TL0 | |
| MIVAIFLLLVDLMHR | 11 | A0A087X1C5 | |
| PEGTLLNMVLRRMHR | 36 | O95398 | |
| MHRPEAMLLLLTLAL | 31 | Q96DA0 | |
| QRDLELPDMHMRDLV | 766 | Q8IXK0 | |
| AIPELMRILVDLERM | 346 | P11217 | |
| LMLVEEELRRDHPAM | 1266 | Q96PV0 | |
| LEVRMDRLLPHMHNI | 251 | Q92973 | |
| LHRRTMMERLHLFPD | 116 | Q9BYD1 | |
| PRHMMRLDIRSLLQD | 1991 | P49750 | |
| FHDLLRREPMLRMQE | 806 | Q8WUA4 | |
| LAVAQRDHMLRGMPL | 156 | Q7Z403 | |
| DPNHFLMIMLSRFEL | 706 | Q8IWV8 | |
| MLNMLIVFRFLRIIP | 546 | Q8NHX9 | |
| MLLLFHSKRMPVAEA | 1 | Q8IU80 | |
| EFMARLMEHVRLPLL | 236 | O95198 |